SEARCH

SEARCH BY CITATION

References

  • 1
    Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993; 119: 31223.
  • 2
    Low TLK, Thurman GB, McAdoo M, et al. Isolation, characterization and biological activities of thymosin α1 and polypeptide β1 from calf thymus. J Biol Chem 1979; 254: 9816.
  • 3
    Schulof RA, Low TLK, Thurman GB, Goldstein AL. Thymosins and other hormones of the thymus gland. In: Sell K, ed. The Lymphocyte. New York: Liss, 1981: 191–215.
  • 4
    Low TLK & Goldstein AL. Thymosins: structure, function, and therapeutic applications. Thymus 1984; 6: 2743.
  • 5
    Cochrane Library. Cochrane Database of Systematic Reviews. Update Software, 2000. Disk issue 2. Oxford: Cochrane Library, 2000.
  • 6
    Andreone P, Cursaro C, Gramenzi A, et al.Preliminary results of thymosin-α1 versus IFN-α treatment in patients with HBeAg negative and HBV-DNA positive chronic active hepatitis. Int J Immunother 1993; IX: 2015.
  • 7
    Andreone P, Curmela C, Gramenzi A, et al.A randomized controlled trial of thymosin-α1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody- and hepatitis B virus DNA-positive chronic hepatitis B. Hepatology 1996; 24: 7747.
  • 8
    Rezakovic I, Mondazzi L, Asti L, Ideo G. Thymosin α1 versus α2 interferon treatment of HBsAg, HBeAb, HBV-DNA positive chronic active hepatitis. Hepatology 1992; 16: 67A67A.
  • 9
    Mutchnick MG, Lee HH, Haynes GD, Hoofnagle JH, Appelman HO. Thymosin treatment of chronic active hepatitis B (CAHB): a preliminary report on a controlled, double blind study. Hepatology 1988; 8: 12701270.
  • 10
    Mutchnick MG, Appelman HD, Chung HT, et al.Thymosin treatment of chronic hepatitis B. A placebo-controlled pilot trial. Hepatology 1991; 14: 40915.
  • 11
    Mutchnick MG, Jaurequi JI, Shafritz DA. Sustained response to thymosin therapy in patients with chronic hepatitis B. Hepatology 1992; 16: 66A66A.
  • 12
    Chien RN, Liaw YF, Chen TC, Yew CT, Sheen IS. Efficacy of thymosin α1 in patients with chronic hepatitis B. A randomized, controlled trial. Hepatology 1998; 27: 13837.
  • 13
    Chow WC, Ng KY, Mcscnas S, Law NM, Ng HS. The interim results of thymosin alpha 1 in a randomized controlled study in the treatment of chronic hepatitis B patients: Singapore experience. Hepatology 1998; 28: 586A586A.
  • 14
    Mutchnick MG, Lindsay KL, Schiff ER, et al.Thymosin α1 treatment of chronic hepatitis B: results of phase III multicentre, randomized, double-blind and placebo-controlled study. J Viral Hepat 1999; 6: 397403.DOI: 10.1046/j.1365-2893.1999.00181.x
  • 15
    Zavaglia C, Severini R, Tinelli C, et al.A randomized, controlled study of thymosin-α1 therapy in patients with anti-HBe, HBV DNA-positive chronic hepatitis B. Dig Dis Sci 2000; 45: 6906.
  • 16
    DerSimonian R & Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 17788.
  • 17
    Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a single, graphical test. Br Med J 1997; 315: 62934.
  • 18
    Tang JL & Liu J. Misleading funnel plot for detection of bias in meta-analysis. J Clin Epidemiol 2000; 53: 47784.
  • 19
    McIntosh MW. The population risk as explanatory variable in research in synthesis of clinical trials. Stat Med 1996; 15: 171328.